arrow
N

Nicolás Ortonne

INSERM
H指数:50
被引数:8,793

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recurrent TNC::PDGFD Fusions in Ossifying Plexiform Tumors of the Skin

皮肤骨化性丛状肿瘤中反复出现的TNC::PDGFD融合现象

2026-08-010
PRE
Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets

神经纤维瘤1中具有非典型特征的神经纤维瘤的免疫景观特征揭示PD-1和Tim-3/Galectin-9通路作为潜在治疗靶点

2026-05-030
OAAI
Prognostic classification of skin adnexal carcinomas: results from a prospective study of 980 patients in the French CARADERM network.

皮肤附属器癌的预后分类:来自法国CARADERM网络一项包含980例患者的前瞻性研究结果。

2026-04-010
PRE
Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model

肿瘤雪旺细胞的神经胶质-间质转化驱动1型神经纤维瘤病小鼠模型mpnst的遗传负担

2025-11-120
PRE
Genetic landscape of non-UV-induced cutaneous squamous cell carcinomas

非UV诱导性皮肤鳞状细胞癌的遗传景观

2025-10-240
PRE
Comprehensive Molecular Profiling of Cribriform Tumors: Identification of Recurrent 6q/9q Codeletion and CD38 Expression

Cribriform肿瘤的全面分子表征:鉴定出复发性6q/9q共缺失和CD38表达

2025-09-120
PRE
Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model

阿扎胞苷在患者来源的异种移植滤泡辅助T细胞淋巴瘤模型中诱导p53介导的凋亡

LEUKEMIA
IF13.4
2025-05-200
OAAI
Potential Role for IL-33 in the Amplification of CD8+ T-Cell–Mediated Cytotoxic Responses in Epidermal Necrolysis

IL-33在增强CD8+ T细胞介导的皮肤坏死性表皮松解症中的潜在作用

2025-02-200
PRE
Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients
2024-12-040
PRE
Primary cutaneous marginal zone Lymphoma or Lymphoproliferative disorder?Comparison of initial tumor, recurrence and outcome in 61 patients
2024-10-010
PRE
Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series
2024-08-120
PRE
Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1
2024-08-012
PRE